Catherine Mazzacco - Jun 30, 2024 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Director
Signature
/s/ Krish Krishnan, as attorney-in-fact for Catherine Mazzacco
Stock symbol
KRYS
Transactions as of
Jun 30, 2024
Transactions value $
$0
Form type
4
Date filed
7/1/2024, 07:29 PM
Previous filing
Jun 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRYS Stock Option (Right to Buy) Award $0 +5K $0.00 5K Jun 30, 2024 Common Stock 5K $183.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were awarded on June 30, 2024 and vest in equal monthly tranches over a one-year period.